albumin human · Ge Healthcare · NDA 020899
Optison
Earliest generic entry, as listed
9 May 2028
Blocked by exclusivity: NPP.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 1 unexpired
| NPP | new patient population | 9 May 2028 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 020899 · 001 · RLD | injectable, injection | 10MG/ML | 9 May 2028 |